Methyldihydromorphine
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (5α,6α)-6-methoxy- 17-methyl- 4,5-epoxymorphinan- 3-ol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Schedule I (US) |
| Identifiers | |
| CAS number | 7732-92-5  |
| ATC code | None |
| PubChem | CID 5463907 |
| UNII | 26AY9TLO5W  |
| Synonyms | Dihydroheterocodeine |
| Chemical data | |
| Formula | C18H23NO3 |
| Mol. mass | 301.38 g/mol |
| SMILES | eMolecules & PubChem |
 (what is this?) (verify) |
|
Methyldihydromorphine (Dihydroheterocodeine)[1] is a semi-synthetic opioid drug developed in Germany in 1936, controlled under both domestic law and UN conventions because of its possible potential for abuse. Methyldihydromorphine is related to heterocodeine and is not a synonym for dihydrocodeine, and its structure suggests that it is six to nine times stronger than morphine and 72 times stronger than dihydrocodeine.
[edit] References
- ^ US Patent 2104058
 |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
